A pioneer in the pharmaceutical industry, LAPROPHAN has distinguished itself for over 75 years through its commitment to innovation and excellence. Our mission: to make innovative therapeutic solutions accessible while contributing to public health improvements in Morocco and beyond. Our production unit, equipped with the latest technology, ensures superior quality healthcare products. With a portfolio of over 420 specialties and 160 pharmaceutical forms, we meet the needs of patients and healthcare professionals globally. At LAPROPHAN, we dedicate ourselves to researching, developing, and bringing innovative products to market. Our patient-centric care is reflected in every action, from product development to service delivery. Join us in shaping the future of healthcare.
| Website | https://laprophan.com |
| Revenue | $32.8 million |
| Employees | 516 (268 on RocketReach) |
| Founded | 1949 |
| Phone | +212 80-1000180 |
| Industry | Pharmaceutical Manufacturing |
| Keywords | Pharmaceutical, Therapeutics, Therapeutic Solutions, Drugs, Medications, Healthcare, Innovation, Prescription Drugs, Treatment, Health Solutions, Biotechnology, Public Health, Research, Development, Manufacturing, Generic Drugs, Clinical Trials, Over The Counter |
| Competitors | Genentech, Amgen, BioMarin Pharmaceutical Inc., Avidity Biosciences, Inc., CureVac, Lilly India, XBiotech USA, Inc., Baxter Research Center, Inc., Neon Therapeutics, The Nanotech Company. LLC +42 more (view full list) |
Looking for a particular Laprophan employee's phone or email?
The Laprophan annual revenue was $32.8 million in 2026.
Azzedine Fezzazi is the CTO GROUP - Comex Member of Laprophan.
268 people are employed at Laprophan.